Advaxis awarded $210

Advaxis awarded $210,000 for development of a dual antigen vaccine Advaxis, Incorporated , the live, attenuated Listeria monocytogenes vaccine organization, offers been awarded a $210,000 grant from the united states National Institute of Wellness to develop a single bioengineered Lm vaccine to provide two different antigen-adjuvant proteins. Related StoriesNew study may offer strategies for developing toxoplasma-inactivated vaccineNew vaccine appears to be far better in reducing 'bad' LDL cholesterolResearchers reveal why malaria vaccine provides only moderate security among vaccinated childrenThis technology enables a single vaccine to simultaneously attack two separate and distinctive tumor targets with a higher degree of potency. Moore .